Pholcodine cough medicines cancelled by the TGA
01 Mar 2023
The investigation followed a link being found between pholcodine-containing medicines and an increased risk of anaphylactic reactions to some of the medicines used as muscle relaxants (neuromuscular blocking agents) during general anaesthesia.
Pholcodine is used in a range of over the counter pharmacy medicines to treat dry cough, particularly in syrups and lozenges.
It is also used in combination with other medicines in products that treat the symptoms of cold and flu.
The TGA’s advice for people who need general anaesthesia and who have taken pholcodine in the past 12 months, is to make your health professional aware.
Health professionals should also check whether patients scheduled to undergo general anaesthesia have used pholcodine in the previous 12 months.
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
- Medicine Shortage
Popular Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy